GMAB: Genmab A/S ADS Stocks News on July 27, 2024

GMAB

Zacks

a day ago

GMAB vs. CSLLY: Which Stock Is the Better Value Option?

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024

GMAB

GlobeNewswire

10 days ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024

GMAB

MT Newswires

12 days ago

RBC Upgrades Genmab to Outperform From Sector Perform, Keeps Price Target at DKK2,400

GMAB

Zacks

17 days ago

GMAB or TECH: Which Is the Better Value Stock Right Now?

GMAB

Zacks

18 days ago

GMAB vs. TECH: Which Stock Is the Better Value Option?

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use

GMAB

Zacks

25 days ago

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use

GMAB

MT Newswires

a month ago

AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment

$Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma$

GMAB

Business Wire

a month ago

Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma

GMAB

GlobeNewswire

a month ago

Completion of Share Buy-back Program

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

GMAB

Zacks

a month ago

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

GMAB

MT Newswires

a month ago

BTIG Adjusts Price Target on Genmab to $47 From $46, Maintains Buy Rating

GMAB

MT Newswires

a month ago

Genmab Gets FDA Approval for Follicular Lymphoma Treatment

$EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)$

GMAB

Business Wire

a month ago

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Transactions in Connection with Share Buy-back Program

GMAB

GlobeNewswire

a month ago

Transactions in Connection with Share Buy-back Program

Capital Increase in Genmab as a Result of Employee Warrant Exercise

GMAB

GlobeNewswire

a month ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

GMAB

GlobeNewswire

a month ago

Transactions in Connection with Share Buy-back Program

Grant of Restricted Stock Units and Warrants to Employees in Genmab

GMAB

GlobeNewswire

a month ago

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

GMAB

GlobeNewswire

a month ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

GMAB

PR Newswire

2 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

GMAB

Business Wire

2 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

GMAB

AFP

2 months ago

New Zealand scraps plan to tax livestock burps, farts

GMAB

Business Wire

2 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

GMAB

The Wall Street Journal

2 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

GMAB

Bloomberg

2 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

GMAB

Simply Wall St.

2 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

GMAB

Simply Wall St.

2 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

GMAB

GlobeNewswire

2 months ago

Transactions in Connection with Share Buy-back Program

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

GMAB

Business Wire

2 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GMAB

GlobeNewswire

2 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GMAB

GlobeNewswire

2 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

GMAB

Simply Wall St.

2 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

GMAB

Reuters

2 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

GMAB

AFP

2 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GMAB

GlobeNewswire

2 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

GMAB

PR Newswire

2 months ago

Enduring role of 'treasuring the past' hailed

Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference

GMAB

GlobeNewswire

2 months ago

Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference

GMAB

MT Newswires

2 months ago

Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating

GMAB

MT Newswires

2 months ago

Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study

GMAB

GlobeNewswire

2 months ago

Transactions in Connection with Share Buy-back Program

Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

GMAB

Business Wire

2 months ago

Investigational Tisotumab Vedotin Phase 2 Data Demonstrates Encouraging Antitumor Activity in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC

GMAB

Clinical Trials Arena

2 months ago

Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC

Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma

GMAB

Business Wire

2 months ago

Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma

GMAB

GlobeNewswire

2 months ago

Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)

GMAB

Business Wire

2 months ago

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)

GMAB

GlobeNewswire

2 months ago

Transactions in Connection with Share Buy-back Program

Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting

GMAB

Business Wire

2 months ago

Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

GMAB

Pharmaceutical Technology

2 months ago

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Genmab Completes Acquisition of ProfoundBio

GMAB

Business Wire

2 months ago

Genmab Completes Acquisition of ProfoundBio

GMAB

GlobeNewswire

2 months ago

Transactions in Connection with Share Buy-back Program

GMAB

MT Newswires

2 months ago

Market Chatter: Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress

GMAB

Business Wire

2 months ago

Genmab to Present New and Updated Results From Multiple Clinical Trials Evaluating Epcoritamab Across Various B-Cell Malignancies at the 2024 European Hematology Association (EHA) Congress

Danish biotech says companies should tap into China’s ‘impressive innovation’

GMAB

Financial Times

2 months ago

Danish biotech says companies should tap into China’s ‘impressive innovation’

GMAB

GlobeNewswire

2 months ago

Transactions in Connection with Share Buy-back Program

GMAB

GlobeNewswire

3 months ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

GMAB

GlobeNewswire

3 months ago

Transactions in Connection with Share Buy-back Program

GMAB

Morningstar Research

3 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

GMAB

Insider Monkey

3 months ago

Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript

GMAB

MT Newswires

3 months ago

Genmab Reports Higher Interim Q1 Results; Maintains 2024 Guidance

Genmab Announces Financial Results for the First Quarter of 2024

GMAB

GlobeNewswire

3 months ago

Genmab Announces Financial Results for the First Quarter of 2024

GMAB

GuruFocus.com

3 months ago

Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...

Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer

GMAB

Pharmaceutical Technology

3 months ago

Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

GMAB

Business Wire

3 months ago

TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

GMAB

Business Wire

3 months ago

FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

Transactions in Connection with Share Buy-back Program Genmab

GMAB

GlobeNewswire

3 months ago

Transactions in Connection with Share Buy-back Program Genmab

GMAB

GlobeNewswire

3 months ago

Transactions in Connection with Share Buy-back Program Genmab

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024

GMAB

GlobeNewswire

3 months ago

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024

Roche reports survival data for new dual-acting lymphoma drug

GMAB

BioPharma Dive

3 months ago

Roche reports survival data for new dual-acting lymphoma drug

GMAB

GlobeNewswire

3 months ago

Transactions in Connection with Share Buy-back Program Genmab

GMAB

GlobeNewswire

4 months ago

Transactions in Connection with Share Buy-back Program

Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover

GMAB

Investor's Business Daily

4 months ago

Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover

Stocks to Watch Wednesday: Disney, Intel, Tesla, Trump Media

GMAB

The Wall Street Journal

4 months ago

Stocks to Watch Wednesday: Disney, Intel, Tesla, Trump Media

Genmab buys ProfoundBio for $1.8B, adding to ADC dealmaking flurry

GMAB

BioPharma Dive

4 months ago

Genmab buys ProfoundBio for $1.8B, adding to ADC dealmaking flurry

Genmab Strengthens Oncology Portfolio With $1.8 Bln Acquisition of ProfoundBio

GMAB

The Wall Street Journal

4 months ago

Genmab Strengthens Oncology Portfolio With $1.8 Bln Acquisition of ProfoundBio

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

GMAB

Business Wire

4 months ago

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio

GMAB

GlobeNewswire

4 months ago

Transactions in Connection with Share Buy-back Program

GMAB

GlobeNewswire

4 months ago

Transactions in Connection with Share Buy-back Program

GMAB

GlobeNewswire

4 months ago

Completion of share buy-back program

30 Biggest Biotechnology Companies in the World

GMAB

Insider Monkey

4 months ago

30 Biggest Biotechnology Companies in the World

Genmab Announces Initiation of Share Buy-Back Program

GMAB

GlobeNewswire

4 months ago

Genmab Announces Initiation of Share Buy-Back Program

GMAB

GlobeNewswire

4 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

GMAB

GlobeNewswire

4 months ago

Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab

Passing of Genmab A/S’ Annual General Meeting

GMAB

GlobeNewswire

4 months ago

Passing of Genmab A/S’ Annual General Meeting

GMAB

GlobeNewswire

5 months ago

Transactions in connection with share buy-back program

GMAB

GlobeNewswire

5 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

GMAB

GlobeNewswire

5 months ago

Transactions in connection with share buy-back program

GMAB

GlobeNewswire

5 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

GMAB

GlobeNewswire

5 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

GMAB

GlobeNewswire

5 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

GMAB

GlobeNewswire

5 months ago

Capital Increase in Genmab as a Result of Employee Warrant Exercise

$U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma$

GMAB

Business Wire

5 months ago

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma

GMAB

GlobeNewswire

5 months ago

Transactions in connection with share buy-back program

GMAB

GlobeNewswire

5 months ago

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

GMAB

GlobeNewswire

5 months ago

Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab

GMAB

GlobeNewswire

5 months ago

Transactions in connection with share buy-back program

GMAB

Insider Monkey

5 months ago

Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript

GMAB

GuruFocus.com

5 months ago

Genmab: Growth Is Still a Better Choice

Notice to Convene the Annual General Meeting of Genmab A/S

GMAB

GlobeNewswire

5 months ago

Notice to Convene the Annual General Meeting of Genmab A/S

Genmab Files Annual Report with the U.S. Securities and Exchange Commission

GMAB

GlobeNewswire

5 months ago

Genmab Files Annual Report with the U.S. Securities and Exchange Commission

GMAB

GlobeNewswire

5 months ago

Genmab Announces Initiation of Share Buy-Back Program

GMAB

GlobeNewswire

5 months ago

Latest Genmab A/S ADS (GMAB) News on July 27, 2024

Share on Social Networks: